Literature DB >> 15683614

The role of regulatory T lymphocytes in asthma pathogenesis.

Douglas S Robinson1.   

Abstract

Several subtypes of regulatory or suppressive T cells have been described that can prevent activation of effector T cells in vitro and in vivo in animal models. Recent evidence suggests a deficit in suppressive activity of both CD4(+)CD25(+) regulatory T cells, and interleukin (IL)-10 producing regulatory T cells may play a role in development of allergic sensitization. If therapies can be devised to redress the balance between regulatory and effector T cells, there may be hope for the control and prevention of asthma.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15683614     DOI: 10.1007/s11882-005-0087-8

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.919


  60 in total

Review 1.  Regulatory T cells: key controllers of immunologic self-tolerance.

Authors:  S Sakaguchi
Journal:  Cell       Date:  2000-05-26       Impact factor: 41.582

Review 2.  Regulatory T cells in the control of immune pathology.

Authors:  K J Maloy; F Powrie
Journal:  Nat Immunol       Date:  2001-09       Impact factor: 25.606

3.  Serrate1-induced notch signalling regulates the decision between immunity and tolerance made by peripheral CD4(+) T cells.

Authors:  G F Hoyne; I Le Roux; M Corsin-Jimenez; K Tan; J Dunne; L M Forsyth; M J Dallman; M J Owen; D Ish-Horowicz; J R Lamb
Journal:  Int Immunol       Date:  2000-02       Impact factor: 4.823

4.  IL-10-secreting regulatory T cells do not express Foxp3 but have comparable regulatory function to naturally occurring CD4+CD25+ regulatory T cells.

Authors:  Pedro L Vieira; Jillian R Christensen; Sophie Minaee; Emma J O'Neill; Franck J Barrat; André Boonstra; Thomas Barthlott; Brigitta Stockinger; David C Wraith; Anne O'Garra
Journal:  J Immunol       Date:  2004-05-15       Impact factor: 5.422

5.  Human anergic/suppressive CD4(+)CD25(+) T cells: a highly differentiated and apoptosis-prone population.

Authors:  L S Taams; J Smith; M H Rustin; M Salmon; L W Poulter; A N Akbar
Journal:  Eur J Immunol       Date:  2001-04       Impact factor: 5.532

6.  Human CD4(+)CD25(+) thymocytes and peripheral T cells have immune suppressive activity in vitro.

Authors:  L A Stephens; C Mottet; D Mason; F Powrie
Journal:  Eur J Immunol       Date:  2001-04       Impact factor: 5.532

7.  Human CD4+CD25+ T cells derived from the majority of atopic donors are able to suppress TH1 and TH2 cytokine production.

Authors:  Iris Bellinghausen; Bettina Klostermann; Jürgen Knop; Joachim Saloga
Journal:  J Allergy Clin Immunol       Date:  2003-04       Impact factor: 10.793

8.  Asymptomatic atopy is associated with increased indoleamine 2,3-dioxygenase activity and interleukin-10 production during seasonal allergen exposure.

Authors:  D von Bubnoff; R Fimmers; M Bogdanow; H Matz; S Koch; T Bieber
Journal:  Clin Exp Allergy       Date:  2004-07       Impact factor: 5.018

Review 9.  CD4+ CD25+ suppressor T cells: more questions than answers.

Authors:  Ethan M Shevach
Journal:  Nat Rev Immunol       Date:  2002-06       Impact factor: 53.106

10.  Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood.

Authors:  H Jonuleit; E Schmitt; M Stassen; A Tuettenberg; J Knop; A H Enk
Journal:  J Exp Med       Date:  2001-06-04       Impact factor: 14.307

View more
  14 in total

Review 1.  Interleukin-35 in immune-related diseases: protection or destruction.

Authors:  Junfeng Zhang; Yunsheng Zhang; Qingpeng Wang; Chunlei Li; Hongxin Deng; Chuanping Si; Huabao Xiong
Journal:  Immunology       Date:  2019-03-07       Impact factor: 7.397

Review 2.  Interleukin-10-secreting regulatory T cells in allergy and asthma.

Authors:  Zoë Urry; Emmanuel Xystrakis; Catherine M Hawrylowicz
Journal:  Curr Allergy Asthma Rep       Date:  2006-09       Impact factor: 4.806

3.  Co-inhalation of roflumilast, rather than formoterol, with fluticasone more effectively improves asthma in asthmatic mice.

Authors:  Hussam A Murad; Hamed S Habib; Misbahuddin M Rafeeq; Mansour I Sulaiman; Amer S Abdulrahman; Mohamad Nidal Khabaz
Journal:  Exp Biol Med (Maywood)       Date:  2017-01-05

Review 4.  Inflammatory response, immunosuppression, and cancer recurrence after perioperative blood transfusions.

Authors:  J P Cata; H Wang; V Gottumukkala; J Reuben; D I Sessler
Journal:  Br J Anaesth       Date:  2013-05       Impact factor: 9.166

5.  Disruption of the homeostatic balance between autoaggressive (CD4+CD40+) and regulatory (CD4+CD25+FoxP3+) T cells promotes diabetes.

Authors:  Dan M Waid; Gisela M Vaitaitis; Nathan D Pennock; David H Wagner
Journal:  J Leukoc Biol       Date:  2008-05-09       Impact factor: 4.962

6.  Migration of regulatory T cells toward airway epithelial cells is impaired in chronic rhinosinusitis with nasal polyposis.

Authors:  Yong Min Kim; Amanda Munoz; Peter H Hwang; Kari C Nadeau
Journal:  Clin Immunol       Date:  2010-07-02       Impact factor: 3.969

7.  Fermented fish oil suppresses T helper 1/2 cell response in a mouse model of atopic dermatitis via generation of CD4+CD25+Foxp3+ T cells.

Authors:  Sang-Chul Han; Gyeoung-Jin Kang; Yeong-Jong Ko; Hee-Kyoung Kang; Sang-Wook Moon; Yong-Seok Ann; Eun-Sook Yoo
Journal:  BMC Immunol       Date:  2012-08-09       Impact factor: 3.615

8.  Phase I Dose Escalation Study of Sodium Stibogluconate (SSG), a Protein Tyrosine Phosphatase Inhibitor, Combined with Interferon Alpha for Patients with Solid Tumors.

Authors:  Aung Naing; James M Reuben; Luis H Camacho; Hui Gao; Bang-Ning Lee; Evan N Cohen; Claire Verschraegen; Saneese Stephen; Joann Aaron; David Hong; Jennifer Wheler; Razelle Kurzrock
Journal:  J Cancer       Date:  2011-02-10       Impact factor: 4.207

9.  Selective deregulation in chemokine signaling pathways of CD4+CD25(hi)CD127(lo)/(-) regulatory T cells in human allergic asthma.

Authors:  Khoa D Nguyen; Christopher Vanichsarn; Alison Fohner; Kari C Nadeau
Journal:  J Allergy Clin Immunol       Date:  2009-01-18       Impact factor: 10.793

10.  Increased cytotoxicity of CD4+ invariant NKT cells against CD4+CD25hiCD127lo/- regulatory T cells in allergic asthma.

Authors:  Khoa D Nguyen; Chris Vanichsarn; Kari C Nadeau
Journal:  Eur J Immunol       Date:  2008-07       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.